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Abstract: Background: Radiotherapy is a treatment modality for cancer. For better therapeutic effi-
ciency, it could be used in combination with surgery, chemotherapy or immunotherapy. In addition to 
its beneficial therapeutic effects, exposure to radiation leads to several toxic effects on normal tissues. 
Also, it may induce some changes in genomic expression of tumor cells, thereby increasing the resis-
tance of tumor cells. These changes lead to the appearance of some acute reactions in irradiated organs, 
increased risk of carcinogenesis, and reduction in the therapeutic effect of radiotherapy.  
Discussion: So far, several studies have proposed different targets such as cyclooxygenase-2 (COX-2), 
some toll-like receptors (TLRs), mitogen-activated protein kinases (MAPKs) etc., for the amelioration 
of radiation toxicity and enhancing tumor response. NADPH oxidase includes five NOX and two dual 
oxidases (DUOX1 and DUOX2) subfamilies that through the production of superoxide and hydrogen 
peroxide, play key roles in oxidative stress and several signaling pathways involved in early and late 
effects of ionizing radiation. Chronic ROS production by NOX enzymes can induce genomic instability, 
thereby increasing the risk of carcinogenesis. Also, these enzymes are able to induce cell death, espe-
cially through apoptosis and senescence that may affect tissue function. ROS-derived NADPH oxidase 
causes apoptosis in some organs such as intestine and tongue, which mediate inflammation. Further-
more, continuous ROS production stimulates fibrosis via stimulation of fibroblast differentiation and 
collagen deposition. Evidence has shown that in contrast to normal tissues, the NOX system induces 
tumor resistance to radiotherapy through some mechanisms such as induction of hypoxia, stimulation of 
proliferation, and activation of macrophages. However, there are some contradictory results. Inhibition 
of NADPH oxidase in experimental studies has shown promising results for both normal tissue protec-
tion and tumor sensitization to ionizing radiation.  
Conclusion: In this article, we aimed to review the role of different subfamilies of NADPH oxidase in 
radiation-induced early and late normal tissue toxicities in different organs. 
Keywords: Radiation, radiotherapy, NADPH oxidase, inflammation, genomic instability, fibrosis, tumor resistance, carcino-
genesis, ROS, bystander effect.  
INTRODUCTION 
 Radiotherapy is a treatment modality for cancer and can 
be used in combination with surgery, chemotherapy or  
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immunotherapy [1, 2]. In comparison to surgery, radiother-
apy is less invasive and also has lesser systematic side ef-
fects compared to chemotherapy [3, 4]. Although, immuno-
therapy has the lowest side effects and is a growing modality 
for cancer treatment, it needs further studies. In recent years, 
some studies have proposed that the combination of radio-
therapy with immunotherapy may be more effective com-
pared to other modalities for tumor eradication [5-8]. Besides 
the beneficial therapeutic effects of radiotherapy on tumor 
suppression, normal tissue toxicity is the most limiting factor 
for the delivery of a sufficient radiation dose to tumor cells 
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[9, 10]. So far, several studies have been conducted to ame-
liorate normal tissue damage following exposure to ionizing 
radiation [11]. Amifostine is the most common radioprotec-
tor. However, its high toxicity may cause the discontinuation 
of radiotherapy [12-14]. So far, several experiments have 
shown promising results for low toxic natural and herbal 
agents [15].  
 A knowledge of the mechanisms by which ionizing ra-
diation causes toxicity in normal cells is essential for the 
development of effective radiation modifiers. However, sen-
sitization of tumor cells to ionizing radiation can increase 
therapeutic ratio as well as a reduction in the dose required 
for tumor eradication [16, 17]. Studies have proposed that 
inhibition of several targets following exposure to ionizing 
radiation can attenuate radiation-induced normal tissues 
complications [18]. Studies have shown that the side effects 
of exposure to radiation may originate from the accumula-
tion of DNA damage and cell death, which occurs immedi-
ately some hours after irradiation [19, 20]. Oxidized DNA 
damage and cell death trigger several signaling pathways 
that are involved in early and late effects of radiotherapy. 
Oxidized DNA and necrotic cells through some toll-like re-
ceptors (TLRs) such as TLR2, TLR4, TLR5 and TLR9 
stimulate the regulation of transcription factors like NF-kB, 
leading to the release of inflammatory cytokines by macro-
phages and lymphocytes [21, 22]. On the other hand, apopto-
sis induction, which is a common cell death type following 
exposure to radiation leads to the release of tolerogenic cyto-
kines such as IL-10 and TGF- [23, 24].  
 Both pro-inflammatory and tolerogenic cytokines are 
able to stimulate the upregulation of pro-oxidant enzymes. 
These enzymes, through the continuous production of differ-
ent types of free radicals such as reactive oxygen species 
(ROS) and reactive nitrogen species (RNS) affect cell func-
tion by amplifying radiation toxicity [25]. The simplest ef-
fects of free radical production by pro-oxidant enzymes are 
more DNA damage and cell death, in addition to triggering 
reduction/oxidation reactions that cause further production of 
ROS and nitric oxide (NO) [26, 27]. The most common pro-
oxidant enzymes include NADPH oxidase, cyclooxygenase-
2 (COX-2), iNOS, lipoxygenases (LOX) [28]. The mito-
chondria, a source of energy supply within cells, have a close 
relation withthese enzymes and may produce superoxide 
during oxidative stress conditions [29]. NADPH oxidase 
enzymes include some subfamilies that produce H2O2 for a 
long time following exposure to a foreign stimulus such as 
ionizing radiation [30, 31]. In recent years, some studies 
have proposed a key role for NADPH oxidase enzymes in 
the development of various side effects such as oxidative 
injury, genomic instability, inflammation, fibrosis, and the 
bystander effect.  
NADPH OXIDASE SYSTEM FUNCTION  
 Several studies have shown that NADPH oxidase system 
is the main source of endogenous ROS, which is activated 
following cell exposure to internal or external stimulus [32, 
33]. NADPH oxidase has seven isoforms which include 
NOX1-5 as well as DUOX1 and DUOX2. NOX subfamilies 
have a core structure comprising six transmembrane protein 
domains. In addition, each NOX subfamily uses some com-
bination subunits which are required for the activation of this 
core [34, 35]. Among NOX enzymes, NOX1, NOX2, and 
NOX4 are membrane-dependent. These enzymes require a 
subunit for their function which is named p22phox. Produc-
tion of superoxide anion (O2
-) by NOX1 and NOX2 enzymes 
needs other subunits in addition to RAC GTPase. NOX4 
does not require these proteins for its activity while NOX5 is 
activated by calcium signaling. In contrast to other subfami-
lies of NADPH oxidase, NOX4 and DUOX1&2 produce 
H2O2 [36, 37]. In response to internal danger alarms or for-
eign stimulus, NOX system activates and augments the level 
of O2
- and H2O2 within cells [38]. One of the most important 
functions of NADPH oxidase enzymes is its phagocytic ac-
tivity that leads to the killing of foreign bodies such as mi-
crobes [39].  
DISTRIBUTION OF NADPH OXIDASE  
 NOX family (including DUOX1 and DUOX2) can be 
expressed in various cells. Moreover, in a specific cell type, 
the expression of more than one of these genes is probable 
[40]. NOX1 can be expressed in the epithelium of some or-
gans such as colon, lung and vascular [41]. NOX2 plays a 
key role in phagocytosis in different organs, and is also ex-
pressed in the thyroid, bone marrow, gastrointestinal system 
and kidney cells [42, 43]. Similar to NOX2, NOX3 has 
phagocyte activity and can be expressed by phagocyte cells. 
NOX4 can be expressed by several cells in the lung, kidney, 
brain, vascular, bone marrow, etc. The expression of NOX5 
has been found in fibroblast cells, spleen, testis, and lymph 
nodes. DUOX1 and DUOX2 isoforms are involved in the 
production of thyroid hormones and highly expressed in thy-
rocyte cells [44-46].  
NADPH OXIDASE AND CARCINOGENESIS  
 Several evidences have shown that chronic inflammation 
plays a key role in cancer initiation [47]. Some studies pro-
posed that inflammation is responsible for the incidence of 
up to half of cancers [48-50]. It has been revealed that 
upregulation of inflammatory cytokines such as IL-1 and 
TNF-, TGF-, etc., can increase ROS production following 
upregulation of NADPH oxidase [51]. In addition, some 
growth factors such as platelet-derived growth factor 
(PDGF) and epidermal growth factor (EGF) are able to trig-
ger upregulation of these enzymes [52-55]. It is well known 
that chronic oxidative stress is a hallmark for genomic insta-
bility and cancer induction [56, 57]. Potential carcinogenesis 
role of NADPH oxidase was first identified by Chiera et al. 
They used a model of HeLa cells with high expression of 
NOX1. Overexpression of NOX1 in Hela cells was associ-
ated with the chronic production of ROS and RNS, DNA 
damage and 3-fold increase in HPRT mutation. Authors sug-
gest that chronic oxidative injury in this cell type causes 
saturation of DNA repair responses (DRR), leading to ge-
nomic instability [58]. NOX1 is also able to prevent apopto-
sis of precancerous cells through inhibition of p53 Lys382 
acetylation, which is necessary for apoptosis of malignant 
cells [59]. 
 Increased expression of NADPH oxidase has been ob-
served to be associated with pre-malignant lesions. Upregu-
lation of NOX1, NOX2, and DUOX2 in adenomas of the 
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colon and inflammatory bowel diseases has been detected 
[25, 60, 61]. It is supposed that dysregulation of pathogen 
recognition in the intestine or other organs may induce 
chronic upregulation of NADPH oxidase system and chronic 
oxidative injury [62]. Upregulation of NADPH oxidase is 
associated with increased risk of some other tumor types. 
Also, inhibition of these enzymes has been proposed for re-
ducing the probability of cancer incidence. Han et al., in a 
systematic review and meta-analyses, proposed that there is a 
close link between overexpression of NOX system genes and 
the incidence of lung cancer [63]. Experimental studies pro-
pose a role for NOX1-5 in the promotion of mutagenesis. 
NOX1 can cause mutation of the K-RAS oncogene that plays 
a key role in the development of some malignancies such as 
lung cancer [64]. Increased expression of NOX4 has been 
observed in chronic myeloid leukemia [65]. Also, it has been 
proposed that increased expression of NOX4 has a role in the 
initiation of breast and ovarian cancers [66].  
 In addition, to direct ROS production by NADPH oxi-
dase enzymes, the interaction of these enzymes with other 
redox mediators has a key role in oxidative injury, genomic 
instability, and carcinogenesis [67]. The mitochondria have a 
close relation with NADPH oxidase. Under normal condi-
tions, oxidative phosphorylation with mitochondria causes 
the production of oxygen metabolites including 5% superox-
ide. These superoxide molecules are naturally neutralized by 
antioxidant defense enzymes such as catalase (CAT), super-
oxide dismutase (SOD), glutathione (GSH), glutathione per-
oxidase (GPx) and glutathione reductase (GR). However, 
during oxidative stress conditions, mutations in the mito-
chondrial DNA (mtDNA) increases the production of super-
oxide by the mitochondria and amplify oxidative injury [68]. 
In this situation, antioxidant enzymes are not able to neutral-
ize abnormally increased superoxide production, leading to 
the activation of redox interactions which cause chronic oxi-
dative stress and genomic instability [69]. Some studies pro-
posed that NADPH oxidase activation leads to mutations in 
mtDNA and increased superoxide production [70-72]. Fur-
thermore, NOX4 is able to transport a GFP into the mito-
chondria, leading to ROS production within the mitochon-
dria [66]. 
NADPH OXIDASE IN RADIATION-INDUCED NOR-
MAL TISSUE TOXICITY; POTENTIAL MODIFIERS  
NADPH Oxidase and Radiation-Induced ROS Produc-
tion and Genomic Instability 
 As earlier mentioned, chronic upregulation of NADPH 
oxidase enzymes is associated with continuous ROS produc-
tion which may induce genomic instability and carcinogene-
sis. An in vitro study showed that inhibition of NOX4 or 
NOX5 can mitigate DNA damage caused by ionizing radia-
tion. This study showed that inhibition of these genes with 
fulvene-5 is capable of reducing 35% of double-strand 
breaks (DSBs) in human peripheral blood mononuclear cells. 
Other NOX and DUOXs subfamilies genes did not show 
remarkable expression in these cells [73]. Wang et al. in an 
in vivo study, evaluated chronic oxidative injury in bone 
marrow stem cells following whole body irradiation of mice 
with 6.5 Gy. They observed, up to 2-fold increase in the pro-
duction of ROS in hematopoietic stem cells (HSCs) 2 weeks 
after irradiation. Increased production of ROS continued up 
to the 8th week. Further analyses showed that when mice 
were treated with diphenyleneiodonium chloride (DPI) (an 
inhibitor for all isoforms of NOX system), the production of 
ROS and oxidative DNA damage were significantly attenu-
ated. However, treatment with other inhibitors such as COX-
2 inhibitor, lipoxygenase inhibitor, and mitochondrial inhibi-
tor could not attenuate oxidative injury. Also, they showed 
that when mice were treated with apocynin, NOX enzymes 
except NOX4 were inhibited, while the oxidative injury was 
not mitigated [74]. Another study by Pazhanisamy et al. 
evaluated the role of NOX4 in mice bone marrow in ge-
nomic instability. They showed that chronic upregulation of 
NOX4 is responsible for genomic instability in mice HSCs. 
Inhibition of NOX4 showed that the number of unstable 
 
Fig. (1). Mechanisms of radiation-induced release of danger alarms and cytokine release by macrophages and Lymphocytes-T.  
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chromosomal aberrations reduces significantly. The protec-
tive effect of NOX4 inhibition had a similar effect on mice 
when treated with a potent antioxidant [75]. Similar results 
were obtained after irradiating mice with high energy pro-
tons. Results showed a significant reduction in the number of 
HSCs 22 weeks after irradiation. Results showed a 1.8-fold 
increase in NOX1, a 3-fold increase in NOX2, and a 36-fold 
increase in the expression of NOX4 [76]. Another study by 
Kyung et al. confirmed the role of NOX1 in the radiation-
induced ROS production and DNA damage in irradiated 
cells. Irradiation of human Jurkat T cells leads to a remark-
able increase in the production of ROS and formation of mi-
cronuclei. Similar to some other findings, activation of 
MAPK enzymes plays a key role in ROS production in these 
cells. Inhibition of NOX1 showed reduced ROS production 
and micronuclei formation [77]. 
 It seems that NOX system activation in bone marrow 
cells is induced by upregulating the release of TGF- by 
immune cells, resulting from the high incidence of apoptosis. 
A study by Zhang et al. showed that inhibition of TGF- 
with SB431542 can mitigate radiation toxicity in mice bone 
marrow mononuclear cells (BMMNCs), hematopoietic pro-
genitor cells (HPCs) and HSCs. Moreover, their results indi-
cated that TGF- activation following exposure to radiation 
induces toxicity through upregulation of NOX1, NOX2, and 
NOX4 [78]. Some studies showed that attenuation of these 
genes is involved in radioprotection against ionizing radia-
tion. Li et al. evaluated the potential modulatory effect of 
melatonin and 5-methoxytryptamine--lipoic acid (a combi-
nation of melatonin and -lipoic acid) on the expression of 
NOX4 and ROS production in mice hematopoietic cells fol-
lowing whole body irradiation. They showed that both mela-
tonin and 5-methoxytryptamine--lipoic acid are able to at-
tenuate ROS production and DNA damage through modula-
tion of NOX4 upregulation [79]. Similar results have been 
observed for dark tea extract [80]. Also, treatment with met-
formin or resveratrol can reduce long-term production of 
ROS in hematopoietic cells through suppression of TGF- – 
NOX4 pathway [81, 82].  
 In addition to the NOX system, upregulation of DUOX1 
and DUOX2 may be involved in radiation-induced toxicity 
in some tissues with high expression of these genes. A study 
by El-Hassani et al. revealed high expression of these genes 
following exposure to radiation in thyrocyte cells. They 
showed that exposure of thyrocyte cells to radiation caused 
chronic upregulation of DUOX1 through activation of p38 
by IL-13. They showed that targeting of IL-13 and p38 led to 
a significant reduction in the expression of DUOX1 and 
DSBs. Authors suggested that since DUOX1 is upregulated 
in thyroid cancers, it is possible that radiation through 
chronic upregulation of DUOX1 and continuous production 
of free radicals triggers genomic instability and thyroid can-
cer [83].  
NADPH Oxidase and Radiation-Induced Cell Death 
 Cell death after exposure to ionizing radiation is the most 
critical response of radiosensitive normal tissues that cause 
the appearance of side effects in these organs. Apoptosis 
induction in the bone marrow, intestine, and tongue isone of 
the most important reasons for organ failure following expo-
sure to an acute high dose of radiation. Chronic ROS produc-
tion by pro-oxidant enzymes such as NADPH oxidase en-
zymes is a reason for cell death, especially through apoptosis 
induction. Tateishi et al. evaluated the role of ROS produc-
tion by NOX1 in the apoptosis induction following irradia-
tion of salivary gland cells. Their study showed that inhibi-
tion of NOX1 in normal salivary gland cell lines such as NS-
SV-AC and NSSV-DC leads to significant reduction in ROS 
production and apoptosis. This study showed no significant 
increase in the expression of other NOX system genes in-
cluding NOX2, NOX3, NOX4 or NOX5 [84]. In contrast, a 
study by Wang et al. showed a significant increase in the 
expression of all NOX subfamilies following irradiation of 
HepG2 cells with carbon ions. Their results confirmed that 
upregulation of NOX family enzymes induces cell death 
through the production of free radicals [85].  
 In addition to the direct production of ROS, NADPH 
oxidase enzymes are able to stimulate superoxide production 
by mitochondria, leading to cell death [86]. It has been pro-
posed that NADPH oxidase stimulates mitochondrial-ROS 
production in hematopoietic stem and progenitor cells, lead-
ing to death and inhibition of proliferation following expo-
sure to radiation [87]. 
NADPH Oxidase and Radiation-Induced Bystander Ef-
fect 
 The bystander effect is a radiobiological phenomenon 
which is involved in radiation toxicity through the initiation 
of redox reactions in adjacent non-irradiated cells. Several 
experimental studies have shown that bystander effect causes 
free radical production and genomic instability. Thus, it may 
be involved in second primary cancers after radiotherapy 
[88-91]. For the first time, Narayanan et al. showed that irra-
diation of human lung fibroblasts with alpha particles leads 
to the generation of intracellular superoxide and hydrogen 
peroxide. Their analyses showed that membrane-dependent 
NOX enzymes are responsible for the production of free 
radicals. Moreover, they showed that the activation of these 
enzymes and ROS production do not require direct exposure 
of cells to ionizing radiation and may be induced in adjacent 
cells [92]. Azzam et al. evaluated the possible role of 
NADPH oxidase signaling in micronuclei formation in non-
irradiated human lung fibroblasts. They showed that irradia-
tion of these cells leads to the upregulation of MAPK genes 
such as p38 and ERK, as well as transcription factors such as 
activator protein 1 (AP-1) and NF-kB. This was associated 
with the production of hydrogen peroxide and superoxide, 
while incubation of cells with DPI or ROS scavengers sup-
pressed these changes [93].  
 It has been proposed that the release of oxidized cell-free 
DNA following cell death is a possible mechanism for the 
induction of oxidative stress and genomic instability in by-
stander cells [69]. A study by Sergeeva et al. has shown that 
irradiation of mesenchymal stem cells (MSCs) with a low 
dose of radiation caused upregulation of NOX4 and in-
creased ROS production in bystander cells. They showed 
that increased NOX4 expression is detectable 30 minutes 
after irradiation [94]. Although experimental studies illustrat-
ing the direct role of NOX system in bystander effect are 
limited, there are some evidences for the upregulation of 
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upstream genes of NOX family in bystander cells and tis-
sues. Increased expression of TGF-, p38, ERK1/2, NF-kB 
and other inflammatory mediators such as mitochondrial 
ROS has been confirmed by several studies [95-101].  
NADPH Oxidase and Radiation-Induced Inflammation 
 Some evidences have given an indication about the role 
of NADPH oxidase in inflammatory responses following 
exposure to radiation. Inhibition of NOX system has shown 
promising results for mitigation of some organs. Inhibition 
of NOX enzymes by apocynin ameliorates the infiltration of 
inflammatory cells, epithelial damage and apoptosis induc-
tion in rat’s intestine [102]. Su et al. showed that upregula-
tion of NADPH oxidase and chronic ROS production by 
these enzymes are involved in radiation-induced inflamma-
tory response in mice skin. This study showed that ROS pro-
duction by NADPH oxidase induces p38 and NF-kB, leading 
to the release of prostaglandins (PGs) and inflammatory cy-
tokines such as TNF, IL-1, and IL-6. Targeting NADPH 
oxidase by 18-Glycyrrhetinic acid could mitigate these 
changes and subsequent skin damage [103].  
 Senescence is a type of cell death that has a close relation 
to the NOX system and triggers inflammation. It has been 
shown that irradiation of primary mouse embryonic fibro-
blasts leads to a significant increase in the incidence of se-
nescence. Their results showed a 5-fold increase in the level 
of -galactosidase (a marker of senescence). Also, this study 
showed that among different types of NOX and DUOX iso-
forms, the expression of NOX4 increased significantly. In-
terestingly, this study showed that NOX4 is not responsible 
for senescence, while senescence triggers the expression of 
NOX4 and free radical production. Although, NOX4 gene 
expression is independent of NF-kB, its ROS production 
stimulates the infiltration of inflammatory cells [104].  
 NOX2 plays a key role in chronic oxidative stress in the 
brain cells. Irradiating mice brain (40 Gy/8 fractions/4 
weeks) showed association with increased level of TNF- 
and MCP-1, as well as ROS. These changes were more ob-
vious on the 8th week after irradiation. Selective inhibition of 
NOX-2 with NOX-2 agonist antibody showed a reduction in 
free radicals (less than 20%) compared with irradiated mice 
without NOX-2 agonist antibody [105]. Irradiation of rat’s 
brain microvascular endothelial cells also showed increased 
ROS production through upregulation of NOX2 and NOX4. 
Also, it has been shown that NOX2 is involved in the 
upregulation of NF-kB and ICAM-1 [106]. 
NADPH Oxidase and Radiation-Induced Fibrosis 
 In addition to inflammation, there are some evidences 
suggesting that NADPH oxidase plays a role in the differen-
tiation of myofibroblasts and in the development of fibrosis. 
An in vitro study showed that irradiating primary mice pros-
tate fibroblast cells leads to the activation of NOX4, cell 
senescence and activation of fibroblasts. While inhibition of 
NOX4 leads to inactivation of fibroblasts, reduced cell death 
and inhibition of TGF- – Smad2/3 signaling pathway, 
which plays a central role in the development of fibrosis 
[107]. The pivotal role of NOX system and ROS production 
in the development of radiation-induced fibrosis has been 
confirmed by another study by Park et al. This study showed 
that irradiation of lung fibroblast cells leads to immediate 
ROS production by NOX4. They showed that upregulation 
of p38 and Akt, but not Erk has a role in chronic upregula-
tion of NOX4 and ROS production. Inhibition of NOX4, p38 
or Akt caused the inhibition of ROS production and attenu-
ated the increased expression of -smooth muscle actin (-
SMA), fibronectin (FN) and extracellular matrix (ECM) ac-
cumulation. Results of this study indicated that NOX4 plays 
a central role in redox activation in fibroblast cells, which 
stimulate fibrosis through continuous ROS production [108]. 
Inhibition of p38 following exposure to ionizing radiation 
has been shown to attenuate redox activation and continuous 
production of ROS. This was associated with reduced cell 
senescence, induced by the NOX system [109]. 
 Choi et al. evaluated the possible role of NOX1, NOX2, 
and NOX4 in the myofibroblasts following irradiation of 
human pulmonary artery endothelial cells (HPAECs). They 
showed that inhibition of NOX2 and NOX4 had no remark-
able effect on fibrotic changes. However, NOX1 inhibition 
caused significant attenuation of fibrotic changes. In addi-
tion, targeting each of these genes led to a reduction in ROS 
production. Also, in an in vivo study, they showed that sup-
pression of NOX1 is associated with a reduction in the ex-
pression of pro-fibrotic genes such as -smooth muscle actin 
(SMA) as well as amelioration of collagen deposition 
[110]. Results of this study were confirmed by another study 
conducted by Citrin et al. They evaluated the expression of 
different genes using microarray analysis and also histologi-
cal changes following irradiation of mice lungs. Results 
showed that radiation-induced cell death through senescence 
in airway cells plays a key role in the initiation of fibrosis.  
 Since the NOX system is responsible for senescence, 
they investigated the role of NOX genes in this process. 
Their results showed that when NOX enzymes were inhib-
ited by DPI, the induction of senescence in airway cells and 
fibrosis was attenuated remarkably [111]. Chen et al. de-
tected the ROS production and collagen deposition at 1 and 5 
months after irradiating murine lungs with 15 Gy. They 
showed significantly elevated production of ROS at 1 month 
and collagen deposition at both 1 and 5 months after irradia-
tion. Moreover, their results showed that ROS production by 
NOX2 and NOX4 in activated macrophages is the main 
source of free radical production. Also, ROS-derived NOX 
enzymes could induce myofibroblast activity and collagen 
deposition. In contrast to another study, this study showed 
that NOX1 had no significant role in the production of ROS 
by activated macrophages. Upregulation of NOX system was 
attenuated through the inhibition of NF-kB [112]. 
NADPH OXIDASE IN TUMOR RESPONSES TO RA-
DIOTHERAPY  
 The activation of immune cells and redox reactions have 
complicated effects on killing and resistance of tumor cells 
to therapeutic strategies, including radiotherapy. Activated 
macrophages play a key role in redox activity via regulation 
of some pro-oxidant enzymes such as NADPH oxidase and 
iNOS [113]. The role of ROS and NO produced by these 
enzymes is a double-edged sword [114]. ROS and NO have 
detrimental effects on cancer cells because of the induction 
of DNA damage and suppression of DNA repair mechanisms 
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[114-116]. NO derived activated macrophage is able to in-
duce apoptosis through the accumulation of p53 which is 
necessary for the initiation of apoptosis. Moreover, it can 
stimulate the downregulation of Bcl-2 and causes damage to 
mitochondria [117]. Moreover, NO through S-nitrosylation 
of p50 inhibits the regulation of NF-kB and downstream 
signaling including the release of prostaglandins by COX-2 
[118]. NF-kB – COX-2 signaling plays a key role in tumor 
resistance via inhibition of apoptosis [119]. Thus, NO can 
facilitate apoptosis through targeting of this pathway [120]. 
By contrast, there are several studies that proposed an 
adaptation of cancer cells to radiation following exposure to 
free radicals [121, 122]. It has been suggested that the 
adaptive response of cancer cells results from high rate muta-
tion in cancer genome, induction of hypoxic factors, angio-
genesis, and stimulation of cancer stem cells proliferation 
[123, 124].  
 In contrast to the toxic effects of NOX and DUOX en-
zymes on normal cells, some experimental studies have 
shown a radioresistance role for these enzymes in tumor 
cells. It has been revealed that upregulation of NOX4 
through stimulation of the PI3k/Akt pathway increases both 
the resistance of cancer cells to apoptosis and survival [65]. 
Similar results have been observed for non-small cell lung 
cancer (NSCLC). Zhang et al. showed that the expression of 
NOX4 is increased in samples obtained from patients with 
NSCLC. They showed that upregulation of NOX4 has a 
close correlation with tumor resistance and patient survival. 
Moreover, their results indicated that NOX4 has a direct re-
lationship with the PI3k/Akt pathway and tumor invasion 
[125]. You et al. evaluated the expression of different sub-
families of NADPH oxidase in gastric cancer cells. They 
showed a high expression of NOX1, NOX2, and NOX4, but 
no significant increase in the expression of NOX5 as well as 
DUOX1 and DUOX2 is observed. Moreover, their results 
indicated that high expression of NOX4 has an indirect cor-
relation with patient survival [126].  
 It has been confirmed that NADPH oxidase activity can 
induce resistance to radiotherapy and chemotherapy agents, 
thus reducing the therapeutic effects of these modalities. Lu 
et al. evaluated the role of NOX family in prostate cancer 
cell response to ionizing radiation. This is crucial for andro-
gen therapy, which is a common modality for increasing 
therapeutic ratio. Hormonal therapy was associated with a 
significant increase in the expression of NOX2 and NOX4, 
but not NOX5. Inhibition of these enzymes by apocynin or 
DPI could sensitize prostate cancer cells to ionizing radiation 
[127]. The role of NADPH oxidase in radioresistance of tu-
mor cells through induction of hypoxia has been detected. 
Hypoxia is a well-known phenomenon in different types of 
solid tumors, which play a key role in tumor growth and re-
sistance to radiotherapy. In the hypoxic area of the tumor 
microenvironment, NOX4 stimulates the regulation of HIF-
1, which is a key modulator of tumor angiogenesis through 
the upregulation of VEGF. Inhibition of NOX4 in glioblas-
toma-bearing mice tumor attenuates resistance of this tumor 
to radiation [128].  
 ROS production by NOX enzymes or other pro-oxidant 
enzymes is responsible for HIF-1 upregulation and tumor 
radioresistance [129]. Moreover, ROS production by NOX 
system can upregulate p38, which promotes radioresistance 
of G0 cells [130]. Also, it causes the activation of PTEN and 
its downstream genes such as protein kinase B (Akt), which 
is similar to p38 in stimulating the proliferation of tumor 
cells. This may be involved in the radioresistance of 
glioblastoma cells [131]. A study by Wu et al. proposed the 
role of ROS-derived NOX2 in the development of inflamma-
tion and radioresistance of advanced rectal cancer cells. They 
showed that NOX2, through stimulation of ataxia telangiec-
tasia mutated (ATM) kinase stimulates the activation of 
macrophages and their infiltration in the tumor. They pro-
posed that targeting NOX2 may lead to poorer resistance of 
tumor cells through the reprogramming of macrophage infil-
tration in tumor cells [132].  
 In contrast to the aforementioned evidences for the role 
of NADPH oxidase in radioresistance of tumor cells, it has 
been reported that DUOX2 upregulation sensitizes gastric 
cancer cells [133]. Also, it has been shown that the upregula-
 
Fig. (2). The mechanisms of radiation-induced NADPH oxidase activation and normal tissue toxicity.  
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tion of NADPH oxidase in prostate cancer cells attenuates 
antioxidant defense through suppression of reduced thiore-
doxin and also the inhibition of FOXO3a, which causes at-
tenuation of SOD and CAT. Hence, stimulation of NADPH 
oxidase by parthenolide induced-ROS elevation and attenua-
tion of antioxidant defense in prostate cancer cells, leads to 
sensitization of PC3 cells to radiation [134].  
CONCLUSION 
 As mentioned in this review, there are some evidences 
suggesting that all subfamilies of NADPH oxidase (includ-
ing NOX1-5 and DUOX1&2) are involved in toxic effects of 
ionizing radiation on normal tissues through amplification of 
ROS production. Evidences from in vitro and in vivo studies 
proposed that it is possible that NADPH oxidase activity is 
initiated some minutes after exposure to radiation and may 
continue for a long time, depending on the irradiated 
cells/organs. Some in vivo studies showed upregulation of 
NOX enzymes in bone marrow cells some weeks after irra-
diation, while ROS production is obvious even after one year 
in intestinal cells. In addition to the direct role of NOX1-5 
and DUOX1&2 in ROS production, these enzymes are able 
to trigger other redox mediators such as the mitochondria 
that amplify oxidative stress in a positive feedback loop. 
This leads to more DNA damage and cell death by stimulat-
ing more release of pro-inflammatory and pro-fibrotic cyto-
kines.  
 Several studies showed that NOX1-5 and DUOX1&2 
play a key role in acute reactions like apoptosis of bone mar-
row and gastrointestinal system as well as late effects of ra-
diotherapy such as inflammation and fibrosis. Acute cell 
death in radiosensitive organs such as bone marrow, tongue, 
and small intestine is a major cause of mucositis and lym-
phopenia for patients with head and neck as well as abdomen 
and pelvic cancers. Modulation of appropriate targets is one 
of the most important aims in alleviating radiation toxicity in 
these organs. In experimental studies, inhibition of NOX 
system and DUOX1&2 showed promising results for sup-
pression of apoptosis, as well as amelioration of genomic 
instability, which is a hallmark for increased risk of second 
primary cancers following radiotherapy. Moreover, suppres-
sion of NOX1, NOX2, NOX4, and NOX5 has shown inter-
esting results which can help attenuate fibrosis following 
radiotherapy. Experimental studies indicate potential modu-
latory effects of some radioprotectors such as metformin, 
melatonin, and resveratrol on the expression of these genes. 
 In contrast to toxic effects on normal tissues, some 
evidences have shown that different subfamilies of the NOX 
system increase the resistance of tumor cells to ionizing ra-
diation. Evidences from some limited studies proposed that 
ROS production by NOX system plays a central role in the 
proliferation of tumor cell, via induction of hypoxia and 
stimulation of angiogenesis. Hence, suggesting that the acti-
vation of p38 by ROS-derived NOX enzymes is a key me-
diator for the proliferation of tumor cells.  
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